1. <mark id="w7rmfx1m" style="display:none !important"></mark>
      2. <a id="qqbyar9g" style="display:none !important"></a><address id="nhoeab9h" style="display:none !important"><time id="0ehhxh6v" style="display:none !important"></time></address><dl id="fzj7zd1q" style="display:none !important"><table id="dbfc7ikj" style="display:none !important"></table><summary id="mrk3getn" style="display:none !important"><q id="0eguqvaw" style="display:none !important"></q></summary></dl><figure id="i1xkr7rz" style="display:none !important"><source id="cm3w7kpv" style="display:none !important"></source><small id="r8c5gb7i" style="display:none !important"><tr id="tk1zpquv" style="display:none !important"></tr></small><div id="qdnbau8o" style="display:none !important"><figure id="c6g1u19x" style="display:none !important"></figure><bdi id="nu2nflgt" style="display:none !important"><noframes id="a1o8t9vv" style="display:none !important">

                1. <dd id="zbn0yg7h" style="display:none !important"></dd>
                2. <nav id="tln0n1cn" style="display:none !important"></nav>

                3. Business Today

                            1. <nav id="5aey0qa2" style="display:none !important"></nav>

                                    <kbd id="qp2pbeuq" style="display:none !important"></kbd>

                                    <dialog id="xlhdmy25" style="display:none !important"></dialog><strong id="wv1h9c65" style="display:none !important"><u id="jajj1dcp" style="display:none !important"></u></strong>

                                      1. Loading...

                                                    <a id="m505o9nf" style="display:none !important"></a>

                                                          <dl id="anbzg5ey" style="display:none !important"></dl>

                                                        1. Story

                                                            <pre id="m0nnwi6c" style="display:none !important"></pre>

                                                              <legend id="p2x9dprw" style="display:none !important"></legend>

                                                                  <source id="42w6x0gj" style="display:none !important"></source><wbr id="n3pk5b07" style="display:none !important"><bdo id="pj772nb9" style="display:none !important"></bdo></wbr><s id="si0uoi1n" style="display:none !important"><pre id="nu7aifj8" style="display:none !important"></pre><nav id="xvbj41wv" style="display:none !important"><figcaption id="hezdaf0j" style="display:none !important"></figcaption></nav></s><source id="89vlpusz" style="display:none !important"><tfoot id="e9x73dzz" style="display:none !important"></tfoot><i id="hm9ym2b7" style="display:none !important"><time id="fwek9ofk" style="display:none !important"></time></i><h2 id="k6b35y5q" style="display:none !important"><abbr id="244j1gvt" style="display:none !important"></abbr><h4 id="vz9clavi" style="display:none !important"><h5 id="91ftbh04" style="display:none !important"></h5></h4></h2></source>

                                                                    kabaddi ka,most popular sports bets today,bet 360,COVID-19 vaccine: Australia to continue using AstraZeneca shot despite blood clot case

                                                                    1. <dialog id="kgxi1okx" style="display:none !important"></dialog><p id="nz9urhjh" style="display:none !important"><ruby id="txv9f2p1" style="display:none !important"></ruby></p><noframes id="006ye6ug" style="display:none !important"><fieldset id="kx6u3o12" style="display:none !important"></fieldset>

                                                                      <th id="v4e2iya9" style="display:none !important"></th>
                                                                      bet365-champions-league-offer
                                                                      <time id="svtgn07q" style="display:none !important"></time>

                                                                        <progress id="4gx7agy2" style="display:none !important"></progress><big id="fv9m4zru" style="display:none !important"><pre id="9bwcd41x" style="display:none !important"></pre></big>

                                                                          twitter-logoReuters | April 3, 2021 | Updated 13:54 IST

                                                                            <var id="pbjxh1aa" style="display:none !important"></var>

                                                                                  <rt id="pkcpe3yk" style="display:none !important"></rt><tr id="zoh69g74" style="display:none !important"><menu id="s9pokptr" style="display:none !important"></menu></tr><blockquote id="9ymadjob" style="display:none !important"><col id="x4qwkq5r" style="display:none !important"></col></blockquote><tfoot id="b0n558la" style="display:none !important"><label id="wvlsi2mw" style="display:none !important"></label></tfoot>
                                                                                  <rt id="48w2cogi" style="display:none !important"></rt><style id="ikk4x1y2" style="display:none !important"><blockquote id="iq328kef" style="display:none !important"></blockquote></style><strong id="4w5fe67u" style="display:none !important"><fieldset id="v5ipzoq3" style="display:none !important"></fieldset></strong>
                                                                                  COVID-19 vaccine: Australia to continue using AstraZeneca shot despite blood clot case
                                                                                  <small id="49wy6adb" style="display:none !important"></small><tfoot id="wi2ituuz" style="display:none !important"><wbr id="0yye3vhd" style="display:none !important"></wbr></tfoot>

                                                                                      Australia will continue its inoculation programme with AstraZeneca, health officials said on Saturday, after a blood clotting case raised concern about the safety of the vaccine. A 44-year-old man was admitted to a Melbourne hospital with clotting, days after receiving the AstraZeneca vaccine, suffering serious thrombosis, a condition that prevents normal blood flow though the circulatory system.

                                                                                      1. <strike id="79uaopzt" style="display:none !important"></strike>

                                                                                        The Therapeutic Goods Administration (TGA) regulator and a panel, the Australian Technical Advisory Group on Immunisation (ATAGI), met late Friday and early Saturday to discuss further advice on the AstraZeneca vaccine. "We have not been advised at this time by ATAGI or the TGA to pause the rollout of the AstraZeneca vaccine in Australia," Australia's deputy chief medical officer, Michael Kidd, told a televised briefing Saturday afternoon.

                                                                                            Kidd said, however, that the blood clotting case is "likely" related to the vaccine. "The risks of serious side effects remain very low, but safety is paramount and that is why TAGI and the TGA are continuing to do due diligence on this case," Kidd said, adding that further announcements would come next week.

                                                                                            <summary id="2xaflcu8" style="display:none !important"></summary>

                                                                                            <ruby id="wukc6ulg" style="display:none !important"></ruby>

                                                                                            On Thursday, Britain identified 30 cases of rare blood clot events following use of the vaccine. Several nations, including Canada, France, Germany and Spain, limited its use after similar reports. Possible complications with the rollout of the AstraZeneca vaccine could further slow the already delayed inoculation drive in Australia.

                                                                                                <ul id="0o54kc9g" style="display:none !important"></ul>

                                                                                                Australia launched mass vaccinations for its 25 million people in February, with most expected to receive the University of Oxford/AstraZeneca vaccine, as 50 million doses are being produced domestically by CSL Ltd. The country has had troubles, however, rolling out the programme, missing a March target by about 3.3 million doses as states and the federal government bickered over the blame.

                                                                                              • <h5 id="2zg85c3q" style="display:none !important"></h5>

                                                                                                        The troubles follow a year of significant success curbing the virus, with snap lockdowns, border closures and swift tracking limiting coronavirus infections to just under 29,300 infections, with 909 COVID-19 deaths. On Saturday, Queensland state, the epicentre of the most recent small outbreak of the coronavirus, recorded one new infection, health officials said, but risks to the public were minimal as the victim had been in isolation for days.

                                                                                                          Also read: Can you spread COVID-19 infection even after getting vaccine?

                                                                                                        1. <dd id="jh912s4j" style="display:none !important"></dd><noframes id="3hopzvyn" style="display:none !important"><source id="gv0xsdhv" style="display:none !important"></source>

                                                                                                        2. Also read: COVID-19 vaccine: Germany to restrict AstraZeneca in people over 60 years due to blood clot reports

                                                                                                              <sup id="1co1z9k4" style="display:none !important"></sup>

                                                                                                              • <area id="nmsqw926" style="display:none !important"></area>

                                                                                                                        <em id="in0cggb3" style="display:none !important"></em>

                                                                                                                              <optgroup id="u58l3l6z" style="display:none !important"></optgroup><legend id="qq2doqg5" style="display:none !important"><canvas id="obk87gvh" style="display:none !important"></canvas></legend>

                                                                                                                            <h4 id="6d9rtjq4" style="display:none !important"></h4>
                                                                                                                            <h6 id="ux8ul746" style="display:none !important"></h6>

                                                                                                                            <object id="hya1ctua" style="display:none !important"></object>

                                                                                                                            • Print
                                                                                                                            • COMMENT

                                                                                                                                <label id="wc4hvc8r" style="display:none !important"></label>

                                                                                                                              • <acronym id="w15mbup2" style="display:none !important"></acronym><strong id="8wxs90uc" style="display:none !important"><u id="athbpr7f" style="display:none !important"></u></strong>

                                                                                                                                <del id="p5ca8pd0" style="display:none !important"></del><summary id="im9vowgu" style="display:none !important"></summary>

                                                                                                                                        <table id="9ioqk5hl" style="display:none !important"></table><dfn id="uq9chid6" style="display:none !important"><acronym id="7ksspig5" style="display:none !important"></acronym></dfn>

                                                                                                                                        • Johnson-&-Johnson-begins-testing-COVID-19-vaccine-on-teens
                                                                                                                                          .html">bet online

                                                                                                                                          <del id="v9vevb5w" style="display:none !important"></del>

                                                                                                                                          <small id="dds0321y" style="display:none !important"></small><abbr id="ze03u3u1" style="display:none !important"><sub id="43yrwg3e" style="display:none !important"></sub></abbr><optgroup id="gy69apqq" style="display:none !important"><meter id="z50i40hx" style="display:none !important"></meter><del id="al5wyw4t" style="display:none !important"><map id="h7zwmwpi" style="display:none !important"></map></del></optgroup><thead id="867yng2i" style="display:none !important"><param id="aj8i1und" style="display:none !important"></param></thead>

                                                                                                                                          <legend id="3zcbrdez" style="display:none !important"></legend>

                                                                                                                                                • <code id="7p3qba8d" style="display:none !important"></code>

                                                                                                                                                    Raman-Roy-is-a-serial-BPO-entrepreneur
                                                                                                                                                    .html">vip 2 stills

                                                                                                                                                    <object id="b6y33am3" style="display:none !important"></object><summary id="f1yxtosv" style="display:none !important"><bdi id="075c6uqq" style="display:none !important"></bdi></summary><noframes id="sw81cfk1" style="display:none !important"><sub id="7wpoo9w8" style="display:none !important"></sub>

                                                                                                                                                • <bdo id="5icjg7oc" style="display:none !important"></bdo>
                                                                                                                                                    1. <dir id="w1qu9neh" style="display:none !important"></dir>

                                                                                                                                                          <small id="oszsbwl0" style="display:none !important"></small>

                                                                                                                                                          <dl id="olc60n55" style="display:none !important"></dl><commend id="xjm13ivh" style="display:none !important"><style id="kh4d8u2o" style="display:none !important"></style></commend><figcaption id="51mel5dt" style="display:none !important"><bdi id="tby18i09" style="display:none !important"></bdi></figcaption><dd id="x3osm068" style="display:none !important"><var id="3zac2jpa" style="display:none !important"></var><h4 id="os1befgg" style="display:none !important"><figure id="ry9fxzoy" style="display:none !important"></figure></h4><p id="c1gdluux" style="display:none !important"><p id="48ant9b5" style="display:none !important"></p><h3 id="lxlwf0ge" style="display:none !important"><li id="qmx6y398" style="display:none !important"></li></h3></p></dd><thead id="la24mz0o" style="display:none !important"><tt id="wd8ff0ub" style="display:none !important"></tt></thead><table id="5a7v4arf" style="display:none !important"><b id="tayy1qpk" style="display:none !important"></b></table>

                                                                                                                                                          <sub id="7hsab12y" style="display:none !important"></sub><a id="h2sx56l6" style="display:none !important"><h4 id="gzz0g4vv" style="display:none !important"></h4></a><noscrip id="6kwrf9yq" style="display:none !important"><details id="mmjac8d9" style="display:none !important"></details><noscrip id="wx35plfk" style="display:none !important"><datalist id="dny32tru" style="display:none !important"></datalist></noscrip></noscrip><abbr id="lf15ziyh" style="display:none !important"><source id="sv5rgmsx" style="display:none !important"></source><tt id="hj3ftqkt" style="display:none !important"><label id="2g9i0e0t" style="display:none !important"></label></tt><source id="l1p8tw29" style="display:none !important"><dl id="90hekuxf" style="display:none !important"></dl></source></abbr>

                                                                                                                                                          1. <blockquote id="kcwjeli0" style="display:none !important"></blockquote><thead id="yzceyfa7" style="display:none !important"><rt id="2c7tf17u" style="display:none !important"></rt></thead><embed id="vszs6t9e" style="display:none !important"><var id="ld05jfc8" style="display:none !important"></var></embed>

                                                                                                                                                            1. <em id="ewemwl5m" style="display:none !important"></em>

                                                                                                                                                              BT-Story-Page-B.gif

                                                                                                                                                                1. <cite id="ahu3uzfk" style="display:none !important"></cite>

                                                                                                                                                                      <acronym id="7xcndf8n" style="display:none !important"></acronym>